The global market for agentic AI in healthcare is experiencing rapid growth, expected to surge from USD 493.9 million in 2024 to USD 21.1 billion by 2034, with a compound annual growth rate of 46.1%. Agentic AI distinguishes itself from conventional AI by operating autonomously—executing clinical and administrative tasks like diagnostics, treatment planning, and resource allocation without human input. This next-generation AI is being leveraged across a range of healthcare applications, including remote patient monitoring, chronic disease management, and personalized drug discovery. The market is being driven by the increasing demand for personalized medicine, the need to reduce administrative burdens, and the expanding capabilities of AI in processing complex datasets. Companies such as Microsoft, Oracle, NVIDIA, and Thoughtful Automation are among the leading innovators accelerating adoption.
Hippocratic AI plays a notable role in this landscape. In March 2024, the company partnered with NVIDIA to develop emotionally intelligent healthcare agents capable of low-latency, empathetic conversations—enhancing patient engagement through what they call “Empathy Inference.” These agents focus on non-diagnostic tasks like triage and follow-up, relieving clinicians of routine work and improving access to care. Hippocratic AI’s inclusion among the report’s key players signals its rising influence in shaping compassionate and efficient AI-powered healthcare solutions. With North America leading in market adoption due to robust digital infrastructure and proactive investment, the presence of innovators like Hippocratic AI contributes significantly to regional and global momentum.